Navigation Links
Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability
Date:4/23/2008

Company reports more than 60 orders for faster form of image-guided

intensity-modulated radiation therapy

PALO ALTO, Calif., April 23 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) today announced it has received more than 60 orders for its new RapidArc radiotherapy product for faster image-guided intensity-modulated radiotherapy (IMRT). RapidArc orders have been concentrated in North America but have also come in from Europe and Asia since the product was introduced to the market in January, according to the company.

"We are delighted with the early interest in RapidArc, which promises to be a formidable weapon in the battle against cancer," says Tim Guertin, president and CEO of Varian Medical Systems. "This represents the strongest demand for any new product in our history and reflects the need for faster, more user-friendly systems that enable clinics to offer more patients greater access to advanced image-guided IMRT treatments with precision and quality. With RapidArc, we are adding to the already-unsurpassed versatility and value of our Clinac(R) and Trilogy(R) accelerators, making it possible for clinics to use a broader range of imaging, motion management, and dose delivery techniques to deliver an optimal cancer treatment for each and every patient." The company expects to begin shipment of the RapidArc product before the end of this month.

RapidArc delivers a complete volumetric IMRT treatment in a single arc of the treatment machine around the patient and makes it possible to deliver advanced image-guided, intensity-modulated radiation therapy (IMRT) two to eight times faster than is possible with conventional IMRT, including helical tomotherapy. Treatment planning analyse
'/>"/>

SOURCE Varian Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Gene Variant Boosts Risk for Stress-Related Ischemia
2. Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation
3. Gene Variant Protects Black Heart Failure Patients
4. Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
5. Varian, Inc. Acquires Oxford Diffraction, Ltd.
6. Gene Variants Linked to Lung Cancer Identified
7. New Ion Trap Mass Spectrometers From Varian, Inc. Offer the Ultimate in Sensitive Detection and High Productivity
8. New High Performance Gas Chromatographs and Analysis Solutions From Varian, Inc. Offer Enhanced Performance and Capabilities for More Applications
9. FASgen Diagnostic Tests Identify Ovarian Cancer Progression and Apoptosis
10. Varian Medical Systems Teams With Cogent Health Solutions to Offer Case Management Software for Cancer Survivorship
11. Gene Variants Can Predict Threat of Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)...mselves from stroke, heart attack, , , ...dicine,s mantras: If you have high blood pressure,...act on your risk of stroke, heart disease and more...essure still aren,t doing a good enough job contro...Control and Prevention study. , "High blood pr...
(Date:11/21/2008)...erm labor , , FRIDAY, Nov. 21 (HealthDay... that activates the uterine muscles for contractio...erapies for preterm labor. , The molecule pros...ace of these uterine muscle cells, keeping them re...archers from Dartmouth Medical School in New Hamps...
(Date:11/21/2008)...swire/ -- During a memorial service in the Capito...bered Lieutenant Governor Catherine Baker Knoll as...c service, and a tireless advocate for the people ...ected lieutenant governor, Catherine was a noted a... "Her family and her faith were driving forces in ...
(Date:11/21/2008)...nst Lennox-Gastaut syndrome , , FRIDAY, ...el (rufinamide) has been approved as a supplementa...Lennox-Gastaut syndrome, the U.S. Food and Drug Ad...as based on results of a four-month clinical trial...patients who took a placebo, those who took the dr...
Breaking Medicine News(10 mins):Health News:High Blood Pressure Stalks Many Americans 2Health News:High Blood Pressure Stalks Many Americans 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:FDA Approves New Drug for Severe Epilepsy 2
...y – A shot in the arm for researchers of biologica...s designed to closely resemble a baby infant’s le... world. // Babybot, the brain child of roboticists...ious effort of mimicking a human infant’s ability ...
...udy undertaken by Ohio State University that chose...tive has shown that these men have no compunctions... Head researcher and lead author of the study Jul...ised at how little regret we found, because you se...
...t from Pharma companies now even the aid of the co...or bird flu. Computers come in very handy //as the...an work for long periods of time without any rest....ems with ease. In UK high powered computers are co...
...w technique that could treat fractured vertebrae a... a radiologist// at the University of California. ... to 10 % of patients with malignant tumors of the ...rofessor of radiology, and San Diego clinician Bas...
Other Medicine News:Health News:Novel Technique To Revolutionize Treatment Of Spinal Tumors 2
(Date:11/19/2008)...e/ -- Posit Science Corporation,researcher, Dan T...science,Annual Conference in Washington, DC this ...it Baby Boomers. The computerized brain plasticit...exercises that target auditory and,language syste...ed,improvements in cognition by improving speed a...
(Date:11/19/2008)... statistical significance , , ISELIN, N.J.,...ation (Nasdaq: PARS ) today announced results fr...Emulsion (NE) drug delivery technology formulated ...multi-center, randomized, double-blinded, placebo-... of the Company,s 3% Diclofenac Diethanolamine Nan...
(Date:11/19/2008)...wswire/ -- Biotech scientists increasingly are app... to better understand the effects of novel drug ca...enetic Engineering & Biotechnology News ( GEN... a new compound,s mechanism of action and eventual...ccording to the November 15 issue of GEN . ( http...
(Date:11/19/2008)... Roche- , , MONTVALE, N.J., Nov. 19 /PRNews...asdaq: MEMY ) today announced that it has achiev...487/MEM 3454, its lead alpha-7 nicotinic receptor ...chizophrenia (CIAS). The Company has randomized 2...0 million payment from its partner Roche. Memory ...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Skystar Bio Pharmaceutical Announces Upcoming Interview With WallSt net 28 www wallst net 29 4134 1Skystar Bio Pharmaceutical Announces Upcoming Interview With WallSt net 28 www wallst net 29 4134 2Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 1370 1Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 1370 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday November 5 2007 1368 1Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday November 5 2007 1368 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday November 5 2007 1368 3Xytis Names Gordon H Busenbark as Chief Financial Officer 576 1Xytis Names Gordon H Busenbark as Chief Financial Officer 576 2
...-AstraZeneca today announced clinical,trial data f...ine,fumarate sustained release), at the European C...monstrated that the SEROQUEL®,sustained releas...se), administered once daily, significantly improv...d by PANSS) and increased the,time to psychiatric ...
...NESS WIRE)--Mar 20, 2007 - Calando,Pharmaceuticals...ity-owned subsidiary of Arrowhead Research Corpora...he Proceedings of the,National Academy of Sciences... first non-human primate study to use multiple, sy...c candidate that is a,nanoparticle containing non-...
Other Medicine Technology:Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 2Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 3Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 4Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 2Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 3Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 4Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 5
... ( Percutaneous Transseptal Ventricular Assist) S...odynamic needs of patients for circulatory support...e specialists have historically used intra-aortic ...usion, but the IABP provides minimal circulatory s...
...s of the HeartMate Left Ventricular Assist System ...owered by wearable batteries that allow the patien..., which is powered by an external Drive Console. B...ve heart and are designed to assist the pumping fu...
...lant has been shown to be a highly effective adjun...cible concentrations of fibrinogen and thrombin, T... of the coagulation cascade to produce a biocompat...nective tissue like a natural plasma clot and stop...
The Icy catheter is inserted into the femoral vein and resides in the inferior vena cava. Saline flow within the balloons creates a proprietary vortex flow pattern which maximizes heat exchange with
Medicine Products: